DESOUZA ERROL B
SEC insider (Form 3/4/5 filer). CIK 0001213895. Director at Alector, Inc. (ALEC) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies DESOUZA ERROL B has filed insider reports for
- Alector, Inc. (ALEC): Director
- Royalty Pharma plc (RPRX): Director
DESOUZA ERROL B
CIK: 0001213895
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
